title: CARD15 polymorphisms in Behçet's disease.
abstract: BACKGROUND
  Behçet's disease (BD) is a chronic multi-system inflammatory disorder of unknown aetiology, which shares many features of the inflammatory bowel diseases (IBDs). CARD15 has recently been identified as the first susceptibility gene in Crohn's disease (CD).
  
  
  OBJECTIVE
  Given certain clinical and pathological similarities between CD and BD, and recent evidence of linkage of BD to the CARD15 genomic region, the aim of this study was to investigate the role of CARD15 variants in determining susceptibility to BD.
  
  
  METHODS
  We studied 374 BD patients from three ethnically homogeneous cohorts (white English, Turkish, and Middle Eastern Arabs of Palestinian and Jordanian descent). Mutation detection of CARD15 was performed by direct sequencing in a subset of patients from each group and the identified variants were genotyped in the complete cohorts. Case-control analyses were carried out with additional stratification by the BD-associated allele, HLA-B*51.
  
  
  RESULTS
  Mutation detection identified six previously described CARD15 polymorphisms at a frequency of > 3%. Additionally, two of the three CD-associated polymorphisms were present, but at low frequency. The frequency of haplotypes, constructed from nine genotyped polymorphisms, demonstrated significant variation between different ethnic groups. However, case-control analyses demonstrated no association between the CARD15 polymorphisms and susceptibility to BD, irrespective of HLA-B*51 status.
  
  
  CONCLUSIONS
  CARD15 variant alleles are not associated with susceptibility to BD. Other shared loci, currently under investigation, may determine susceptibility to both CD and BD.
authors.affiliation: Gastroenterology Unit, University of Oxford, Gibson Laboratories, Radcliffe Infirmary, Oxford, United Kingdom. tariqahmad@doctors.org.uk
authors.forename: T
authors.initials: T
authors.lastname: Ahmad
authors.forename: L
authors.initials: L
authors.lastname: Zhang
authors.forename: F
authors.initials: F
authors.lastname: Gogus
authors.forename: D
authors.initials: D
authors.lastname: Verity
authors.forename: G
authors.initials: G
authors.lastname: Wallace
authors.forename: W
authors.initials: W
authors.lastname: Madanat
authors.forename: F
authors.initials: F
authors.lastname: Fayyad
authors.forename: T
authors.initials: T
authors.lastname: James
authors.forename: M
authors.initials: M
authors.lastname: Neville
authors.forename: C
authors.initials: C
authors.lastname: Kanawati
authors.forename: F
authors.initials: F
authors.lastname: Fortune
authors.forename: A
authors.initials: A
authors.lastname: Celik
authors.forename: M
authors.initials: M
authors.lastname: Stanford
authors.forename: D P
authors.initials: DP
authors.lastname: Jewell
authors.forename: S E
authors.initials: SE
authors.lastname: Marshall
mesh_terms: D018912:Arabs / Q000208:ethnology; D001528:Behcet Syndrome / Q000208:ethnology / Q000235:genetics*; D016022:Case-Control Studies; D004252:DNA Mutational Analysis; D004739:England / Q000208:ethnology; D020022:Genetic Predisposition to Disease; D005838:Genotype; D015235:HLA-B Antigens / Q000235:genetics; D059949:HLA-B51 Antigen; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D007597:Jordan / Q000208:ethnology; D053473:Nod2 Signaling Adaptor Protein; D011110:Polymorphism, Genetic; D014421:Turkey / Q000208:ethnology; D044465:White People / Q000208:ethnology
chemical_list: D015235:HLA-B Antigens; D059949:HLA-B51 Antigen; D047908:Intracellular Signaling Peptides and Proteins; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein